Hypolipidemic influence of Sargassum subrepandum: Mechanism of action

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue SUPPL. 3, 2012, Pages 112-120

  Ahmed, H H ^a   Abdalla, M S ^b   Eskander, E F ^a   Al Khadragy, M F ^b   Massoud, M N ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Helwan University   (Egypt)

Author keywords

Adipokines; Dyslipidemia; Inflammation; Oxidative stress; Sargassum subrepandum

Indexed keywords

ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; METHANOL; PLANT EXTRACT; SARGASSUM SUBREPANDUM EXTRACT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENIC DIET; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DYSLIPIDEMIA; FEMALE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; RAT; REVIEW; SARGASSUM; SARGASSUM SUBREPANDUM; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FEMALE; HYPOLIPIDEMIC AGENTS; LIPIDS; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SARGASSUM;

EID: 84864213102     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. XENOULIS PG, STEINER JM. Lipid metabolism and hyperlipidemia in dogs. Vet J 2010; 183: 12-21.
2. ZIMMET P, THOMAS CR. Genotype, obesity and cardiovascular disease - has technical and social advancement outstripped evolution. J Intern Med 2003; 254: 114-125.
3. ATTAWAY DH, ZABORSKY OR. Marine biotechnology. J Pharm Bioac Nat Prod 1993; 23: 25.
4. LAHAYE M. Marine algae as sources of fibres : determination of soluble and insoluble dietary fiber contents in some sea vegetables. J Sci Food Agric 1991; 54: 587-594.
5. SOUTHGATE DA. The role of dietary fibre in the diet. J Res Soc Health 1990; 110: 174-178.
6. TAJBAKHSH S, POUYAN M, ZANDI K, BAHRAMIAN P, SARTAVI K, FOULADVAND M, ASAYESH G. AND BARAZESH A. In vitro study of antibacterial activity of the alga Sargassum oligocystum from the Persian Gulf. Eur Rev Med Pharmacol Sci 2011; 15 (3): 293-298.
7. ZANDI K, AHMADZADEH S, TAJBAKHSH S, RASTIAN Z, YOUSEFI F, FARSHADPOUR F, SARTAVI K. Anticancer activity of Sargassum oligocystum water extract against human cancer cell lines. Eur Rev Med Pharmacol Sci 2010; 14: 669-673.
8. AUGER C, CAPORICCIO B, LANDRAULT N, TEISSEDRE PL, LAURENT C, CROS G, BESANCON P, ROUANET J. Red wine phenolic compounds reduce plasma lipids and Apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden Syrian Hamsters (Mesocricetus auratus). J Nutr 2002; 132: 1207-1213.
9. RAGHAVENDRAN HR, SATHIVEL A, DEVAKI T. Effect of sargassum polycystum (Phaeophyceae)-sulphated polysaccharide extract against acetaminophen- induced hyperlipidemia during toxic hepatitis in experimental rats. Mol Cell Biochem 2005; 276: 89-96.
10. ALLAIN CC, POON LS, CHAN CS, RICHMOND W, FU PC. Enzymztic determination of total serum cholesterol. Clin Chem 1974; 20: 470-475.
11. FASSATI P, PRENCIPE L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077-2080.
12. WIELAND H, SEIDEL D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res 1983; 24: 904 -909.
13. BURSTEIN M, SCHOLNICK HR, MORFIN R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; Ll: 583-595.
14. OHKAWA H, OHISHI W, YAGI K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351- 358.
15. MONTGOMERY HAC, DYMOCK JF. Determination of nitric oxide. Analyst 1961; 86: 41-43.
16. KEIM NL. Relation between circulating leptin cocentrations and appetite during a prolonged, moderate energy deficit in women. Am j Clin Nut 1998; 68: 794-801.
17. SERIOLO B, PAOLINO S, SULLI A, FASCIOLO D, CUTOLO M. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis. Ann NY Acad Sci 2006; 1069:414-419.
18. RYAN AS, BERMAN DM, NICKLAS BJ, SINHA M, GINGERICH RL, MENEILLY GS, EGAN JM, ELAHI D. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003; 26: 2383-2388.
19. VAN DEENEN LLM, DE GIER J. Chemical composition and metabolism of lipids in red cells of various animals species In: Bishop C, Surgenor DM 1964.
20. NABEL EG. Cardiovascular disease. N Engl J Med 2003; 349: 60-72.
21. YUGARANI T, TAN BK, TEH M, DAS NP. Effects of Polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 1992; 27: 181- 186.
22. KRITCHEVSKY D, TEPPER SA, BISES G, KLURFELD D. Experimental atherosclerosis in rabbits fed cholesterol- free diet. Part 10. Cocoa butter and palm oil. Atherosclerosis 1982; 41: 279-284.
23. BROWN MS, GOLDSTEIN JL. Lowering plasma cholesterol by raising LDL receptors. N Engl J Med 1981; 305: 515-517.
24. GURR MI, BORLAK N, GANATRA S. Dietary fat and plasma lipids. Nutr Res 1989; 2: 63-86.
25. MATTSON FH, GRUNDY SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lip Res 1985; 26: 194-202.
26. HAGHJOOYJAVANMARD S, NEMATBAKHSH M, SOLEIMANI M. The effect of hypercholesterolemia on serum vascular endothelial growth factor and nitrite concentrations in early stage of atherosclerosis in rabbits. Pakistan J Nutr 2009; 8: 86-89.
27. CSONT T, BERECZKI E, BENCSIK P, FODOR G, GORBE A, ZVARA A, CSONKA C, PUSKAS LG, SANTHA M, FERDINANDY P. Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res 2007; 76: 100-109.
28. MORAN JM, ORTIZ-ORTIZ MA, RUIZ-MESA LM, FUENTES JM. Nitric oxide in paraquat-mediated toxicity J. Biochem Mol Toxicol 2010; 24: 402-409.
29. ESPOSITO LA, MELOV S, PANOV A. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci 1999; 96: 4820-4825.
30. NISHIYAMA Y, IKEDA H, HARAMAKI N, YOSHIDA N, IMAIZUMI T. Oxidative stress is related to exercise intolerance in patients with heart failure. Am Heart J 1998; 135: 115-120.
31. CURZIO M, ESTERBAUER H, POLI G, BIASI F, CECCHINI G, DIMAUROC C, CAPPELLO N, DIANZANI MU. Possible role of aldehydic lipid peroxidation products as chemoattractants. Int J Tiss React 1987; 9:295-306.
32. FURUKAWA S, FUJITA T, SHIMABUKURO M, IWAKI M, YAMADA Y, NAKAJIMA Y, NAKAYAMA O, MAKISHIMA M, MATSUDA M, SHIMOMURA I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
33. CARO JF, KOLACZYNSKI JW, NYCE MR, OHANNESIAN JP, OPENTANOVA I, GOLDMAN WH, LYNN RB, ZHANG P, SINHA MK, CONSIDINE RV. Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
34. FLIER JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004; 116: 337-350.
35. MARGONI A, PERREA DN, VLACHOS L, PROKOPAKI G, PANTOPOULOU A, FOTIS L, KOSTAKI M, PAPAVASSILIOU AG. Serum leptin, adiponectin and tumor necrosis factor (TNF)-α in hyperlipidemic rats with/without concomitant diabetes mellitus. Mol Med 2010(In press).
36. HOTAMISLIGIL GS, SHARGILL NS, SPIEGELMAN BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259 (5091): 87-91.
37. BARZILAI N, SHE L, LIU BQ, VUGUIN P, COHEN P, XU H, UYSAL K T, BECHERER JD, ARNER P, HOTAMISLIGIL GS. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes 2002; 51: 1876-1883.
38. XU H, UYSAL KT, BECHERER JD, ARNER P, HOTAMISLIGIL GS. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes 2002; 51: 1876-1883.
39. STEPHEN EB, CHRISTINE FC. High fat diet induces increased tissue expression of TNF-α. Life Sciences 2005; 77: 2156-2165.
40. IWAKI M, MATSUDA M, MAEDA N, FUNAHASHI T, MATSUZAWA Y, MAKISHIMA M, SHIMOMURA I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52: 1655-1663.
41. YAMAUCHI T, KAMON J, WAKI H, TERAUCHI Y, N. KUBOTA N. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.
42. TAKAHASHI HI, YOUKO H, SHIOMI T, AYAKAWA Y, MIYATA N. Decrease of the plasma cholesterol level by administration of Dunaliella extract in exogenous hypercholemic mice. Aicho Ika Daigaku Igakkai Zasshi 2000; 28: 249-255.
43. MAEDA H, HOSOKAWA M, SASHIMA T, FUNAYAMA K, MIYASHITA K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem Biophys Res Comm 2005; 332: 392-397.
44. MIYASHITA K. Anti-obesity by marine lipids. Eds 2007; 463-475.
45. WOO MN, JEON SM, KIM H, LEE MK, SHIN SK, SHIN YC, PARK YB, CHOI MS. Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice. Chem Biol Interact 2010; 186: 316-322.
46. SHENG L, QIAN Z, ZHENG S, XI L. Mechanism of hypolipidemic effect of crocin in rats:crocin inhibits pancreatic lipase. Eur J Pharmacol 2006; 543: 116-122.
47. NICOLLE N, CARDINAULT O, APRIKIAN J, BUSSEROLLES P, GROLIER E, ROCK C, DEMIGNE A, MAZUR A, SCALBERT P, AMOUROUX C. Effect of carrot intake on cholesterol metabolism and on antioxidant status in cholesterol- fed rat. Eur J Nutr 2003; 42: 254-261.
48. MATSUMOTO M, HOSOKAWA M, MATSUKAWA N, HAGIO M, SHINOKI A, NISHIMUKAI M, MIYASHITA K, YAJIMA T, HARA H. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. Eur J Nutr 2009; 49: 243-249.
49. ZULET MA, BARBER A, GARCIN H, HIGUERET P, MARTÍNEZ JA. Alterations in car- bohydrate and lipid metabolism induced by a diet rich in coconut oil and cholesterol in a rat model. J Am Coll Nutr 1999; 18: 36-42.
50. RAZ R, ELDOR S, CERNEA E. Diabetes, insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev 2005; 21: 3-14.
51. WATANABE K, IWATA K, TANDAI L. Effects of soluble sodium alginates on the excretion of cholesterol, Trp-P-1 and aflatoxin B1 in rats. Eis Kagaku 1992; 38: 258-262.
52. ANGGADIREDJA J, HASANUDIN A, PRATOMO S, RUDYANSYAH A. Screening of marine algae from Warambadi seashore of Sumba island of Indonesia for antibacterial activity. Phytomedicine 1996; Suppl I: 37.
53. DAUGHERTY A, ZWEIFEL BS, SCHONFELD G. The effects of probucol on the progression of atherosclerosis in mature watanabe heritable hyperlipidemic rabbits. Br J Pharmacol 1991; 103: 1013-1018.
54. TALL AR. Plasma high density lipoproteins metabolism and relationship to atherogenesis. J Clin Invest 1990; 86: 379-384.
55. YAN XJ, CHUDA Y, SUZUKI M, NAGATA T. Fucoxanthin as the 4. major antioxidant in Hijikia fusiformis, a common edible seaweed. Biosci Biotechnol Biochem 1999; 63: 605-607.
56. SIES H, STAHL W. Carotenoids and intercellular communication via gap junctions. Int J Vit Nutr Res 1997; 67: 364-367.
57. SHIRATORI K, OHGAMIA K, ILIEVAA I, JINA X, KOYAMAB Y, MIYASHITA K, YOSHIDAA K, KASEA S, OHNOA S. Effects of fucoxanthin on lipopolysaccharide- induced inflammation in vitro and in vivo. Exper Eye Res 2005; 81: 422-428.
58. CHANG YC, LI PC, CHEN BC, CHANG MS, WANG JL, CHIU WT, LIN CH. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappa B pathways. Cell. Signal 2006; 18:1235-1243.
59. POSADAS I, TERENCIO MC, GUILLÉN I, FERRÁNDIZ ML, COLOMA J, PAYÁ M, ALCARAZ MJ. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn Schmiedeberg's Arch Pharmacol 2000; 361: 98-106.
60. HEO SJ, YOON WJ, KIM KN, AHN GN, KANG SM, KANG DH, AFFAN A, OH C, JUNG WK, JEON YJ. Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharidestimulated RAW 264.7 macrophages. Food Chem. Toxicol 2010; 8: 2045-2051.
61. MAEDA H, HOSOKAWA M, SASHIMA T, TAKAHASHI N, KAWADA T, MIYASHITA K. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-l1 cells. Int J Mol Med 2006; 18: 147-152.
62. KIM KN, HEO SJ, YOON WJ, KANG SM, AHN G, YI TH, JEON YJ. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW macrophages. Eur J Pharm 2010; 649: 369-375.
63. BARNES PJ, KARIN M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
64. MIYASHIT K, HOSOKAWA M. Antiobesity effect of Allenic Carotenoid, Fucoxanthin. In Nutrigenomics and Proteomics in Health and Disease. Food Factors and Gene Interactions (chapter 11) 2009; 145-160.